Skip to main content
Erschienen in: Archives of Virology 7/2013

01.07.2013 | Original Article

Detection of human cytomegalovirus in transbronchial biopsies from lung transplant recipients

verfasst von: Cristina Costa, Antonio Curtoni, Francesca Sidoti, Cinzia Balloco, Salvatore Simeone, Samantha Mantovani, Elsa Piasentin Alessio, Daniela Libertucci, Luisa Delsedime, Paolo Solidoro, Sergio Baldi, Rossana Cavallo

Erschienen in: Archives of Virology | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

The role of human cytomegalovirus (HCMV) in lung transplantation (LT) and drawbacks related to viral quantification in bronchoalveolar lavage (BAL) underline the potential usefulness of investigating other specimens. Thirty-three LT recipients were prospectively studied by HCMV quantitative real time PCR on matched transbronchial biopsy (TBB), BAL, and whole blood specimens. Overall, 27/33 patients turned out HCMV-positive in at least one specimen: 7.1 %, 37.1 %, and 13.5 % of TBB, BAL, and blood samples, respectively. No significant association between HCMV on all types of specimens and acute rejection, lymphocytic bronchiolitis, bronchiolitis obliterans and bronchiolitis obliterans syndrome was found. HCMV pneumonia was associated to HCMV detection on TBB (p = 0.003) and whole blood (p = 0.008), not on BAL (p = 0.47). The highest mean viral load was detected in TBB from cases with HCMV pneumonia in comparison to all other cases, suggesting the potential use of HCMV investigation in TBB for evaluating posttransplant complications.
Literatur
1.
Zurück zum Zitat Costa C, Curtoni A, Bergallo M et al (2011) Quantitative detection of HHV-6 and HHV-7 in transbronchial biopsies from lung transplant recipients. New Microbiol 34:275–280PubMed Costa C, Curtoni A, Bergallo M et al (2011) Quantitative detection of HHV-6 and HHV-7 in transbronchial biopsies from lung transplant recipients. New Microbiol 34:275–280PubMed
2.
Zurück zum Zitat Zedtwitz-Liebenstein K, Jaksch P, Bauer C et al (2004) Association of cytomegalovirus DNA concentration in epithelial lining fluid and symptomatic cytomegalovirus infection in lung transplant recipients. Transplantation 77:1897–1899PubMedCrossRef Zedtwitz-Liebenstein K, Jaksch P, Bauer C et al (2004) Association of cytomegalovirus DNA concentration in epithelial lining fluid and symptomatic cytomegalovirus infection in lung transplant recipients. Transplantation 77:1897–1899PubMedCrossRef
3.
Zurück zum Zitat Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC (2004) Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. J Infect Dis 190:1076–1083PubMedCrossRef Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC (2004) Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. J Infect Dis 190:1076–1083PubMedCrossRef
4.
Zurück zum Zitat Solidoro P, Delsedime L, Bergallo M et al (2009) Combined prophylaxis decreases incidence of CMV-associated pneumonia after lung transplantation. Transplant Proc 41:1347–1348PubMedCrossRef Solidoro P, Delsedime L, Bergallo M et al (2009) Combined prophylaxis decreases incidence of CMV-associated pneumonia after lung transplantation. Transplant Proc 41:1347–1348PubMedCrossRef
5.
Zurück zum Zitat Costa C, Libertucci D, Solidoro et al (2007) Rapid shell vial culture for the detection of respiratory viruses from bronchoalveolar lavage in immunocompromised patients. Panminerva Med 49:1–6 Costa C, Libertucci D, Solidoro et al (2007) Rapid shell vial culture for the detection of respiratory viruses from bronchoalveolar lavage in immunocompromised patients. Panminerva Med 49:1–6
6.
Zurück zum Zitat Gerna G, Lilleri D, Furione M, Baldanti F (2011) Management of human cytomegalovirus infection in transplantation: validation of virologic cut-offs for preemptive therapy and immunological cut-offs for protection. New Microbiol 34:229–254PubMed Gerna G, Lilleri D, Furione M, Baldanti F (2011) Management of human cytomegalovirus infection in transplantation: validation of virologic cut-offs for preemptive therapy and immunological cut-offs for protection. New Microbiol 34:229–254PubMed
7.
Zurück zum Zitat Estenne M, Maurer JR, Boehler A et al (2002) Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21:297–310PubMedCrossRef Estenne M, Maurer JR, Boehler A et al (2002) Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21:297–310PubMedCrossRef
8.
Zurück zum Zitat Costa C, Delsedime L, Solidoro P et al (2010) Herpesviruses detection by quantitative real-time polymerase chain reaction in bronchoalveolar lavage and transbronchial biopsy in lung transplant: viral infections and histopathological correlation. Transplant Proc 42:1270–1274PubMedCrossRef Costa C, Delsedime L, Solidoro P et al (2010) Herpesviruses detection by quantitative real-time polymerase chain reaction in bronchoalveolar lavage and transbronchial biopsy in lung transplant: viral infections and histopathological correlation. Transplant Proc 42:1270–1274PubMedCrossRef
9.
Zurück zum Zitat Costa C, Bergallo M, Astegiano S et al (2011) Detection of human rhinoviruses in the lower respiratory tract of lung transplant recipients. Arch Virol 156:1439–1443PubMedCrossRef Costa C, Bergallo M, Astegiano S et al (2011) Detection of human rhinoviruses in the lower respiratory tract of lung transplant recipients. Arch Virol 156:1439–1443PubMedCrossRef
10.
Zurück zum Zitat Costa C, Elia M, Astegiano S et al (2008) Quantitative detection of Epstein-Barr virus in bronchoalveolar lavage from transplant and nontransplant patients. Transplantation 86:1389–1394PubMedCrossRef Costa C, Elia M, Astegiano S et al (2008) Quantitative detection of Epstein-Barr virus in bronchoalveolar lavage from transplant and nontransplant patients. Transplantation 86:1389–1394PubMedCrossRef
11.
Zurück zum Zitat Stewart S, Fishbein MC, Snell GI et al (2007) Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 26:1229–1242PubMedCrossRef Stewart S, Fishbein MC, Snell GI et al (2007) Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 26:1229–1242PubMedCrossRef
12.
Zurück zum Zitat Puchhammer-Stöckl E (2008) Herpesviruses and the transplanted lung: looking at the air side. J Clin Virol 43:415–418PubMedCrossRef Puchhammer-Stöckl E (2008) Herpesviruses and the transplanted lung: looking at the air side. J Clin Virol 43:415–418PubMedCrossRef
13.
Zurück zum Zitat Bauer CC, Jaksch P, Aberle SW et al (2007) Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment. J Clin Microbiol 45:324–328PubMedCrossRef Bauer CC, Jaksch P, Aberle SW et al (2007) Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment. J Clin Microbiol 45:324–328PubMedCrossRef
14.
Zurück zum Zitat Verleden GM, Dupont LJ, Van Raemdonck DE (2005) Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur Respir J 25:221–224PubMedCrossRef Verleden GM, Dupont LJ, Van Raemdonck DE (2005) Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur Respir J 25:221–224PubMedCrossRef
15.
Zurück zum Zitat Chemaly RF, Yen-Lieberman B, Castilla EA et al (2004) Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol 42:2168–2172PubMedCrossRef Chemaly RF, Yen-Lieberman B, Castilla EA et al (2004) Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol 42:2168–2172PubMedCrossRef
16.
Zurück zum Zitat Morbini P, Arbustini E (2001) In situ characterization of human cytomegalovirus infection of bronchiolar cells in human transplanted lung. Virchows Arch 438:558–566PubMedCrossRef Morbini P, Arbustini E (2001) In situ characterization of human cytomegalovirus infection of bronchiolar cells in human transplanted lung. Virchows Arch 438:558–566PubMedCrossRef
17.
Zurück zum Zitat Jacobs F, Knoop C, Brancart F et al (2003) Human herpesvirus-6 infection after lung and heart–lung transplantation: a prospective longitudinal study. Transplantation 75:1996–2001PubMedCrossRef Jacobs F, Knoop C, Brancart F et al (2003) Human herpesvirus-6 infection after lung and heart–lung transplantation: a prospective longitudinal study. Transplantation 75:1996–2001PubMedCrossRef
18.
Zurück zum Zitat Gerna G, Lilleri D, Rognoni V et al (2009) Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients. Am J Transplant 9:1142–1150 Gerna G, Lilleri D, Rognoni V et al (2009) Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients. Am J Transplant 9:1142–1150
Metadaten
Titel
Detection of human cytomegalovirus in transbronchial biopsies from lung transplant recipients
verfasst von
Cristina Costa
Antonio Curtoni
Francesca Sidoti
Cinzia Balloco
Salvatore Simeone
Samantha Mantovani
Elsa Piasentin Alessio
Daniela Libertucci
Luisa Delsedime
Paolo Solidoro
Sergio Baldi
Rossana Cavallo
Publikationsdatum
01.07.2013
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 7/2013
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-013-1607-9

Weitere Artikel der Ausgabe 7/2013

Archives of Virology 7/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.